Sonoma Pharmaceuticals Financial Overview
Sonoma Pharmaceuticals's market cap is currently $6.04M. The company's EPS TTM is $-0.129; its P/E ratio is -1.64; Sonoma Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
